SCHEMBL27618337

SCHEMBL27618337

Cc1cc(C)c2nc(CC(C)(C)C)n(-c3c[c]ccc3)c2n1

nearest known ligand 0.36

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.34
GPR4 P46093 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27597667 0.88 GPR4 (0.41) GPR4
SCHEMBL27597647 0.84 GPR4 (0.41) GPR4
SCHEMBL27597657 0.83 AGTR1 (0.42) GPR4
SCHEMBL7022817 0.77 ALDH1A1 (0.34) ATMGPR4
SCHEMBL7012045 0.77 KDM4E (0.34) ATM
SCHEMBL28751555 0.77 GPR4 (0.33) GPR4
SCHEMBL27597634 0.76
SCHEMBL27618331 0.76 GPR4 (0.34) GPR4
SCHEMBL1624690 0.74 GPR4 (0.35) GPR4
SCHEMBL1625428 0.74 GPR4 (0.35) GPR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100579518-C Use of EP4 receptor ligands for the manufacture of a medicament for the treatment of IL-6 related disorders PFIZER 2010-01-13 CN disclosed
CN-101023946-A Use of EP4 receptor ligands in the treatment of IL-6 involved diseases PFIZER (US) 2007-08-29 CN disclosed
CN-1658847-A Use of EP4 receptor ligands for the treatment of IL-6 related disorders PFIZER (US) 2005-08-24 CN disclosed